These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10520468)

  • 21. An influenza virus temperature-sensitive mutant defective in the nuclear-cytoplasmic transport of the negative-sense viral RNAs.
    Enami K; Qiao Y; Fukuda R; Enami M
    Virology; 1993 Jun; 194(2):822-7. PubMed ID: 8503186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular assembly of influenza virus: association of the NS2 protein with virion matrix.
    Yasuda J; Nakada S; Kato A; Toyoda T; Ishihama A
    Virology; 1993 Sep; 196(1):249-55. PubMed ID: 8356796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction.
    Elster C; Fourest E; Baudin F; Larsen K; Cusack S; Ruigrok RW
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():37-42. PubMed ID: 8113738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1.
    Sha B; Luo M
    Nat Struct Biol; 1997 Mar; 4(3):239-44. PubMed ID: 9164466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influenza virus proteins: preparation of a soluble M1 polypeptide by means of a stepwise deproteination of virions].
    Zhirnov OP
    Mol Biol (Mosk); 1991; 25(2):375-80. PubMed ID: 1881394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza virus Matrix Protein M1 preserves its conformation with pH, changing multimerization state at the priming stage due to electrostatics.
    Shtykova EV; Dadinova LA; Fedorova NV; Golanikov AE; Bogacheva EN; Ksenofontov AL; Baratova LA; Shilova LA; Tashkin VY; Galimzyanov TR; Jeffries CM; Svergun DI; Batishchev OV
    Sci Rep; 2017 Dec; 7(1):16793. PubMed ID: 29196731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simulations of the M2 channel for influenza A virus.
    Forrest LR; Sansom MS
    Biochem Soc Trans; 1998 Aug; 26(3):S303. PubMed ID: 9766022
    [No Abstract]   [Full Text] [Related]  

  • 29. Amphipathic alpha-helices and putative cholesterol binding domains of the influenza virus matrix M1 protein are crucial for virion structure organisation.
    Tsfasman T; Kost V; Markushin S; Lotte V; Koptiaeva I; Bogacheva E; Baratova L; Radyukhin V
    Virus Res; 2015 Dec; 210():114-8. PubMed ID: 26211889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.
    Murakami M; Towatari T; Ohuchi M; Shiota M; Akao M; Okumura Y; Parry MA; Kido H
    Eur J Biochem; 2001 May; 268(10):2847-55. PubMed ID: 11358500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo.
    Perez DR; Donis RO
    Virology; 1998 Sep; 249(1):52-61. PubMed ID: 9740776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
    Huang RB; Du QS; Wang CH; Chou KC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the protonation state of the catalytic residues and ligands upon binding and recognition in targeted proteins of HIV-1 and influenza viruses.
    Nunthaboot N; Rungrotmongkol T; Aruksakunwong O; Hannongbua S
    Curr Pharm Des; 2013; 19(23):4276-90. PubMed ID: 23170886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of monoclonal antibodies against poor immunogenic avian influenza virus proteins.
    He JL; Hsieh MS; Chiu YC; Juang RH; Wang CH
    J Immunol Methods; 2013 Jan; 387(1-2):43-50. PubMed ID: 23022629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of the M2 protein of influenza A virus is not essential for virus viability.
    Thomas JM; Stevens MP; Percy N; Barclay WS
    Virology; 1998 Dec; 252(1):54-64. PubMed ID: 9875317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of aprotinin from porcine lungs.
    de Cássia Dias S; Sakauchi D; Abreu PA; de Lima Netto S; Iourtov D; Raw I; Kubrusly FS
    Biotechnol Lett; 2008 May; 30(5):807-12. PubMed ID: 18071638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a latex agglutination test for detecting antibodies against avian influenza virus based on matrix 1 protein expressed in vitro.
    Wang G; Hu S; Yu X
    Avian Dis; 2010 Mar; 54(1):41-5. PubMed ID: 20408397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High performance liquid chromatography and characterization of structural proteins of the influenza virus].
    Akimenko ZA; Zykov SA; Iastrebov SI; Ofitserov VI
    Bioorg Khim; 1990 Dec; 16(12):1637-42. PubMed ID: 2090114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.
    Liu T; Ye Z
    J Virol; 2004 Sep; 78(18):9585-91. PubMed ID: 15331690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Localization of the influenza virus M1 matrix protein in the virion].
    Ksenofontov AL; Fedorova NV; Badun GA; Timofeeva TA; Grigor'ev VB; Baratova LA; Zhirnov OP
    Mol Biol (Mosk); 1999; 33(5):881-6. PubMed ID: 10579194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.